Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Cigna To Buy Great American Supplemental Benefits For $295 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/11/2012 | 12:28am CET

Cigna Corp. (>> CIGNA Corporation) has agreed to acquire American Financial Group Inc.'s (AFG) Medicare supplement and critical-illness businesses for approximately $295 million in cash, as the managed-care company looks to expand its presence in the individual and seniors markets.

Cigna said its acquisition of Great American Supplemental Benefits Group, one of the largest manufacturers of supplemental health insurance products in the U.S., is expected to close in the second half of 2012.

Great American generated approximately $325 million of revenue last year.

Cigna said the acquisition will expand its individual supplemental offerings to customers in the U.S., bring scaled offerings to the seniors market and extend its direct-to-consumer retail channel.

The deal comes after Cigna bought Medicare carrier HealthSpring Inc. in January for $3.8 billion. The HealthSpring acquisition represented a change in the balance of Cigna, which had primarily focused on employers but will now also be a major source of both Medicare prescription-drug plans and Medicare Advantage coverage, the private insurers' version of the government program.

Cigna has seen its revenue grow in recent quarters, helped by growing membership and a continuing trend of patients using fewer health-care services amid a shaky economy. Last week, the company reported its first-quarter earnings fell 10%, due in part to acquisition costs, though membership growth contributed to better-than-expected revenue.

Meanwhile, American Financial said the deal is expected to be slightly dilutive to its earnings in the short term but will help the company focus on its core businesses.

Cigna shares were up by 11 cents to $45.02 after hours. The stock is up 6.9% so far this year.

-By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; nathalie.tadena@dowjones.com

Stocks mentioned in the article : CIGNA Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
02/24DJTrump to Meet With Insurance Executives on Repeal of Affordable Care Act -- U..
02/24 CIGNA CORP : Change in Directors or Principal Officers (form 8-K)
02/23 CIGNA : Management's Discussion and Analysis of Financial Condition and Results ..
02/23 CIGNA : CFO Thomas McCarthy to retire
02/23 CIGNA CORPORATION (NYSE : CI) Files An 8-K Departure of Directors or Certain Off..
02/23 CIGNA CORP : Change in Directors or Principal Officers, Regulation FD Disclosure..
02/23 CIGNA : Names Four Proven and Tenured Leaders to Executive Team
02/23 CIGNA CORP : Regulation FD Disclosure (form 8-K)
02/22 CIGNA : Winnebago Industries Appoints John Murabito to Its Board of Directors
02/22 CIGNA : Declares Annual Dividend
More news
Sector news : Managed Healthcare - NEC
02/24DJTrump to Meet With Insurance Executives on Repeal of Affordable Care Act -- U..
02/23 CIGNA : CFO Thomas McCarthy to retire
02/17DJAETNA : Doubles Dividend, Boosts Stock Buyback Plans
02/16DJCIGNA : Court Issues Temporary Order Keeping Cigna From Terminating Merger With ..
02/16DJANTHEM : Countersues After Cigna Ends Deal -- WSJ
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
02/24 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2016 Updat..
02/23 Cigna adds to enterprise leadership team, finance chief to retire this summer
02/22 CIGNA declares $0.04 dividend
02/21 Cigna to cover Dermacell dermal matrix; exclusive distributor Novadaq up 9% a..
02/19 Tracking David Einhorn's Portfolio - Q4 2016 Update
Advertisement
Financials ($)
Sales 2017 40 445 M
EBIT 2017 3 393 M
Net income 2017 2 345 M
Finance 2017 98,0 M
Yield 2017 0,02%
P/E ratio 2017 16,15
P/E ratio 2018 13,99
EV / Sales 2017 0,93x
EV / Sales 2018 0,87x
Capitalization 37 751 M
More Financials
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 165 $
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Mark Marsters Senior Vice President-Group Operations
Thomas A. McCarthy Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION10.59%37 751
UNITEDHEALTH GROUP INC1.60%155 097
AETNA INC4.61%45 256
ANTHEM INC14.02%43 159
HUMANA INC0.48%30 952
CENTENE CORP24.90%12 147
More Results